Pharma firms are more data empowered than ever before. New information is being gained daily through clinical trials, drug candidates, sponsors, biomarker development, and mechanisms of action, to name a few. The difficulty is not just in finding data. The hard part is understanding which information is relevant and what each piece of data has to do with each other, and what it does for the next business move. More Info: https://clival.com/blog/pipeline-intelligence-the-new-currency-of-pharmaceutical-strategy